Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Summarization of the POC Blood Gas and Electrolyte, including the initiatives undertaken by the organizations for its improvisation

    Apr 7, 2022, 17:59 PM by
    Global POC Blood Gas and Electrolyte Market share accounted for up to US$1.95 Bn. It is predicted to reach approximately US$3.6 Bn by 2028, with a steady CAGR of 7.89% throughout the time frame of 2020-2028.
    Full story
  • Insightful Science Bolsters Executive Team with Senior Sales and Marketing Expertise to Accelerate Growth Initiatives

    Apr 7, 2022, 17:59 PM by
    Full story
  • Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates

    Apr 7, 2022, 17:59 PM by
    Pfizer Inc. (NYSE: PFE) and ReViral Ltd. announced today that the companies have entered into a definitive agreement under which Pfizer will acquire ReViral, a privately held, clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel antiviral therapeutics that target respiratory syncytial virus (RSV).
    Full story
  • Scientists Finally Finish The Quest For A Gapless Human Genome

    Apr 7, 2022, 01:00 AM by User Not Found
    Bio-IT World | There was no escaping last week’s announcement that the final 8% of the human genome—the equivalent of an entire DNA chromosome—has been sequenced, filling a gap left nearly 20 years after the Human Genome Project declared victory. More than 100 researchers from around the world collaborated on the initiative and many of them, and the institutions they represent, have weighed in on the feat.
    Full story
  • AI Betting Agents Weigh In On Reproducibility Of Research Findings

    Apr 5, 2022, 01:00 AM by User Not Found
    Bio-IT World | Penn State researchers have created synthetic “prediction markets” for speculating on the replicability of published studies with unparalleled accuracy. When betting on published social and behavioral science papers, about 90% of the time bot agents correctly “bought” papers that were eventually reproduced.
    Full story
  • Follow the Money: Single-Cell Analysis, Spatial Biology, Drug-Resistant Infection Treatments, 3D Genomics

    Mar 31, 2022, 01:00 AM by User Not Found
    Bio-IT World | Funds raised for life science company investment, AI-powered single-cell analysis, spatial biology, ML-based discovery of new anti-infectives, and real-time supply chain operations analysis.
    Full story
  • New Illumina Accelerator Start-Ups, Blood Test for Liver Cancer, Several New Collaborations, Software Offerings, More

    Mar 30, 2022, 01:00 AM by User Not Found
    Bio-IT World | A genomic network model is used to identify aurora kinase inhibitor-sensitive lung tumors, new Illumina Accelerator start-ups are announced, AI algorithms are being used to improve prostate cancer identification and treatment, and a blood-based DNA methylation test can detect liver cancer
    Full story
  • Digitization Vs. Digital Transformation at Alnylam

    Mar 29, 2022, 09:00 AM by User Not Found
    Bio-IT World | Jim Bilotta found his home in orphan diseases early in his career, driven by both personal experience and the “unbelievable” impact on patients and their families. Today, as Chief Information Officer, head of IT, at Alnylam, he is still pursuing that impact. In the latest episode of Bio-IT World’s Trends from the Trenches podcast, Bilotta and Trends from the Trenches host, Stan Gloss, discuss digital transformation at Alnylam, and how Bilotta views the distinction between digitization and digital transformation.
    Full story
  • How Life Science Companies Can Harness the Predictive Value of Data to Drive Deeper Process Understanding

    Mar 28, 2022, 01:00 AM by User Not Found
    Bio-IT World | As the biopharmaceutical industry begins to embrace advanced data collection and analysis tools, it finds itself facing a challenging question: How can drug manufacturers best harness all that data to improve capacity, reduce bottlenecks and cut costs? Establishing a strong digital backbone is the first critical step. From there, manufacturers need to figure out how to strengthen this digital backbone with technology that not only makes the data easily accessible, but also empowers manufacturers to analyze it and use it to make transformative predictions.
    Full story
  • Antibody That Opens Blood-Brain Barrier Might Also Ferry Lifesaving Drugs

    Mar 25, 2022, 13:59 PM by User Not Found
    Bio-IT World | A future where single-chain nanobodies and biologically active proteins might voyage through the blood-brain barrier to treat neurological conditions—including Alzheimer’s disease and brain tumors—recently came closer into view with the discovery of an antibody that succeeded in temporarily opening and resealing the crucial filtering mechanism in mice.
    Full story
  • Blueprint For Radically Open, Citizen Science Approach To Aging Research

    Mar 23, 2022, 15:40 PM by User Not Found
    Bio-IT World | Leonid Peshkin, Ph.D., is an unconventional man working at an Ivy League research university in a field he believes is rightfully viewed with “great skepticism” by mainstream biologists. The war on aging he is advancing puts to the test both interventions designed to extend healthspan (the period of life where one is healthy) and our understanding how the ravages of time get undone in the germline, an approach he likens to a Russian “Koschei” fairy tale where the secret to eternal health is in the egg.
    Full story
  • All of Us Program Releases 100K Diverse Whole Genomes

    Mar 18, 2022, 01:00 AM by User Not Found
    Bio-IT World | Nearly 100,000 highly diverse whole genome sequences are now available through the National Institutes of Health's All of Us Research Program, the NIH announced today. About 50% of the data is from individuals who identify with racial or ethnic groups that have historically been underrepresented in research. This data will enable researchers to address yet unanswerable questions about health and disease, leading to new breakthroughs and advancing discoveries to reduce persistent health disparities.
    Full story
  • Zelis Announces New Chief Marketing Officer, Heather Valteris, International Brand Builder and Strategist for Fortune 100 Companies

    Mar 17, 2022, 12:27 PM by
    Full story
  • Curebase and Blue Note Therapeutics Collaborate on Home-based Clinical Trial of Prescription Digital Therapeutics to Help People with Cancer Manage their Health

    Mar 17, 2022, 12:27 PM by
    Curebase and Blue Note Therapeutics Collaborate on Home-based Clinical Trial of Prescription Digital Therapeutics to Help People with Cancer Manage their Health
    Full story
  • Creative Peptides Announces Innovative Services of Peptide Drug Discovery

    Mar 17, 2022, 12:27 PM by
    Creative Peptides announces the release of innovative peptide drug discovery services to support and assist global clients in winning the race of peptide drug development.
    Full story
  • Creative Peptides Rolls Out PNA FISH Probes with High Sensitivity and Specific Hybridization

    Mar 17, 2022, 12:27 PM by
    Creative Peptides rolls out a variety of PNA FISH probe products with high sensitivity and specific hybridization for worldwide customers.
    Full story
  • Useful Approaches for Labeling Peptides with Fluorescent Dyes

    Mar 17, 2022, 12:27 PM by
    Creative Peptides provides useful approaches for labeling peptides with fluorescent dyes
    Full story
  • Lyniate and NextGate Announce Merger Agreement, Advancing Healthcare Interoperability Leadership

    Mar 17, 2022, 12:27 PM by
    Lyniate and NextGate have entered into a merger agreement.
    Full story
  • ProteoGenix Launches New XtenCHO Transient CHO Expression System to Improve Biologics Development

    Mar 17, 2022, 12:27 PM by
    ProteoGenix, a contract research organization specialized in biologics discovery and bioproduction, announces the launch of its XtenCHOTM Transient Expression System.
    Full story
  • Rho Named A 2022 Health Care Leadership Award Winner by Triangle Business Journal

    Mar 17, 2022, 12:27 PM by
    Rho Named A 2022 Health Care Leadership Award Winner by Triangle Business Journal March 14, 2022 - North Carolina-based Triangle Business Journal recently unveiled the winners of its 2022 class of Health Care Leadership Awards, naming Rho as one of this year’s honorees. The global, full-service contract research organization (CRO) was chosen from a pool of Triangle-area nominees that work in a number of health care settings, including major hospital systems, small physician groups, life sciences firms and nonprofit health charities. "The honorees of this year’s Health Care Leadership Awards are making a significant impact on the quality of health care in the Triangle region," said Jason Christie, market president and publisher of TBJ. "This year’s honorees really are heroes in our community. Triangle Business Journal is pleased to honor them.”
    Full story
  • «
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146 (current)
  • 147
  • 148
  • 149
  • 150
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy